Both This medication and the drug represent groundbreaking approaches to managing glucose control, and increasingly, obesity. Tirzepatide is a combined agonist that impacts two hormones involved in metabolism: the incretin hormone and GIP. It, often considered as a trade name for Tirzepatide, ope